Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Chemotherapy Drugs and their Adjuncts (L37205)Article · A55641 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Chemotherapy Agents for Non-Oncologic ConditionsArticle · A55639 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX-CDD: ConfirmMDx Epigenetic Molecular Assay (DL37005).Article · A55540 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Radiation TherapiesArticle · A59547 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-WoundArticle · A59542 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-WoundArticle · A59541 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Diagnostic Tests (MDT) (L36807)Article · A55391 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Polysomnography and Other Sleep Studies (L36839)Article · A55381 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDx: BCR-ABLArticle · A55233 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Scalp Cooling for the Prevention of Chemotherapy-Induced AlopeciaArticle · A59533 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Respiratory CareArticle · A59532 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Respiratory CareArticle · A59531 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59529 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)Article · A59527 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59524 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59523 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59521 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Sacral Nerve Stimulation for the Treatment of Urinary and Fecal IncontinenceArticle · A59520 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59519 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate CancersArticle · A59513 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesArticle · A59509 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyArticle · A59505 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Urinary Biomarkers for Chronic Pain ManagementArticle · A59503 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Urine Drug TestingArticle · A59501 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Trigger Point Injections (TPI)Article · A59498 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Urine Drug TestingArticle · A59496 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Transurethral Waterjet Ablation of the ProstateLCD · L40194 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59484 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisArticle · A59483 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyArticle · A59482 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyArticle · A59476 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesArticle · A59474 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate CancersArticle · A59472 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesArticle · A59470 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate CancersArticle · A59462 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Urine Drug TestingArticle · A59460 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Urine Drug TestingArticle · A59459 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Mohs Micrographic SurgeryArticle · A57477 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | B-type Natriuretic Peptide (BNP) TestingLCD · L33943 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell OriginArticle · A59451 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Oncotype DX® Breast Cancer AssayArticle · A55230 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticle · A59453 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticle · A59452 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: Dental ServicesArticle · A59449 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Transcranial Magnetic Stimulation (TMS)Article · A59444 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: Transcranial Magnetic Stimulation (TMS)Article · A59443 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaArticle · A59441 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaArticle · A59440 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: SULT4A1 Genetic TestingArticle · A55210 | Metadata changed |
|---|
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder CancerArticle · A59437 | Metadata changed |
|---|